4/A//SEC Filing
Aebersold Sarah 4/A
Accession 0001628280-25-014185
CIK 0000834365other
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 7:08 PM ET
Size
5.9 KB
Accession
0001628280-25-014185
Insider Transaction Report
Form 4/AAmended
Aebersold Sarah
Chief Human Resources Officer
Transactions
- Sale
Common Stock
2025-03-17$25.44/sh−2,695$68,561→ 48,797 total
Footnotes (3)
- [F1]The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 12-11-2024.
- [F2]This Form 4 amendment has been filed to correct the amount of securities reported in a Form 4 filed on March 18, 2025. The Form 4 included a sale of 5,632 shares that was improperly included under the reporting person. The correct amount of securities should have been reported as 2,695 in the Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.90 to $25.97, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
BIOLIFE SOLUTIONS INC
CIK 0000834365
Entity typeother
Related Parties
1- filerCIK 0001837756
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 7:08 PM ET
- Size
- 5.9 KB